Clinical Trial Update: TEAVR With False Lumen Embolization for Aortic Dissection

View source ↗

Summary

A clinical trial evaluating TEAVR with false lumen embolization for Type B aortic dissection is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Dissection

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Aortic Dissection Type B | Status: NOT_YET_RECRUITING